Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.

Schleidgen S, Dederer HG, Sgodda S, Cravcisin S, Lüneburg L, Cantz T, Heinemann T

Open source

DOI
10.1186/s12910-020-00487-1
Published
2020 Sep 11
Container
BMC medical ethics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12910-020-00487-1,
  title = {Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.},
  author = {Schleidgen S and Dederer HG and Sgodda S and Cravcisin S and Lüneburg L and Cantz T and Heinemann T},
  year = {2020},
  journal = {BMC medical ethics},
  doi = {10.1186/s12910-020-00487-1},
  url = {https://doi.org/10.1186/s12910-020-00487-1}
}

RIS

TY  - JOUR
TI  - Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
AU  - Schleidgen S
AU  - Dederer HG
AU  - Sgodda S
AU  - Cravcisin S
AU  - Lüneburg L
AU  - Cantz T
AU  - Heinemann T
PY  - 2020
JO  - BMC medical ethics
DO  - 10.1186/s12910-020-00487-1
UR  - https://doi.org/10.1186/s12910-020-00487-1
ER  - 

APA

S, S., HG, D., S, S., S, C., L, L., T, C., & T, H. (2020). Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.. BMC medical ethics. https://doi.org/10.1186/s12910-020-00487-1

Source records